Coronavirus HK: authorities pause AstraZeneca vaccine delivery and order partial evacuation of residential building in Tuen Mun

12-Apr-2021 Intellasia | South China Morning Post | 5:02 AM Print This Post

Hong Kong has asked embattled drug giant AstraZeneca to delay delivery of 7.5 million doses of its Covid-19 vaccine this year and is looking for a second-generation version of the jabs better able to handle new coronavirus variants.

The health minister told lawmakers of the move on Friday as the city confirmed 14 new Covid-19 cases, most of which were imported. Of the two local cases, one was detected in a quarantine centre and the other was untraceable.

About 10 preliminary-positive cases were also being investigated. Among them were a 66-year-old man and a six-year-old boy who live in Oi Fai House in Tuen Mun’s Yau Oi Estate, where two infections had previously been confirmed.

Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge, our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our award-winning team.

After visiting the building in the evening, Professor Yuen Kwok-yung from the University of Hong Kong and an adviser to the government on its pandemic response, suggested residents who lived in “flat 09″ on all floors be evacuated. About 50 residents were affected, according to sources.

Yuen suspected the coronavirus had spread through pipes running from the flat on the 23rd floor where an infected woman lived down to the flat of the 66-year-old living directly below her, and then to the young boy who resided on the 21st floor. Health authorities subsequently endorsed Yuen’s recommendation.

The new infections push Hong Kong’s Covid-19 case tally to 11,562, while the number of related fatalities is now at 207 following the deaths on Friday of a 69-year-old man and an 83-year-old woman.

The city had previously ordered 7.5 million doses from AstraZeneca, which was originally expected to ship the first batch to Hong Kong in the second half of this year.

But the British-Swedish firm, which co-developed the vaccine with Oxford University, has been engulfed in a crisis of confidence, after the European Medicines Agency said unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine.

The revelation prompted local experts, including government adviser Professor David Hui Shu-cheong, to call for the city to reconsider its deal with the company in favour of other options such as the Johnson & Johnson vaccine.

Hui also pointed to data showing that the AstraZeneca vaccine, while 70 per cent effective against the non-mutated coronavirus, offered only 10 per cent protection against a new South African variant.

Ending days of public speculation and administration silence, Secretary for Food and Health Professor Sophia Chan Siu-chee on Friday told the Legislative Council’s panel on health services that the government had told the manufacturer not to deliver its doses as planned this year.

A government source said the shipment would be postponed until the company could tweak its vaccine and improve its efficacy rate against the rapidly spreading South African variant.

“The main reason is because we already have enough supplies,” Chan said, referring to the two batches of 7.5 million shots already ordered from China’s Sinovac and German firm BioNTech.

But Chan said the Health Authority was also concerned about the recent safety reports on the jabs.

“It is not necessary to deliver it to the city this year, to avoid any waste,” she said. “We have also begun looking at next-generation vaccines that can offer better protection against new virus variants.”

Chan declined to comment when asked by lawmakers how much the government had paid the drug giant for the jabs.

The news follows the multinational firm telling the media only a day ago it planned to deliver its shipments to Hong Kong and Macau according to the original agreement. But it is understood that AstraZeneca representatives were told the deal was off in a Thursday meeting.

The company said that while Hong Kong currently had sufficient supply of vaccines, any wastage should be minimised.

“Therefore, AstraZeneca will continue to communicate closely with the … government on the supply and shipment of vaccines to reach a consensus in due course,” it said.

“Regulatory authorities in the United Kingdom and European Union, and the World Health Organization have concluded that the benefits of using Covid-19 vaccine AstraZeneca to protect people from this virus significantly outweigh the risks.”

Since Hong Kong’s vaccination programme began in late February, about 743,600 doses have been administered to the public.

As of Friday, 543,100 people, or 7.2 per cent of Hongkongers, had received their first dose of a Covid-19 vaccine. Of those, some 200,500, amounting to 2.6 per cent of the population, had also been given their second jab.

At Friday’s coronavirus briefing, the Centre for Health Protection’s Dr Chuang Shuk-kwan said the sole untraceable patient from the latest infections was a 42-year-old woman who lived in Yuen Long’s Pak Nai and worked at a Mannings store in Tai Hang Street.

Fifteen of her relatives who recently went grave-sweeping with her, as well as nearly 20 of her colleagues, would have to be quarantined, she added.

Of the 12 new imported cases, six were domestic workers from the Philippines, and the others were from Canada, India, Egypt and Indonesia.


Category: Hong Kong

Print This Post

Leave a Reply

You must be logged in to post a comment.